Jump to content

Stefan Schnekenburger expands the Executive Board and will become chairman

As of September 1, 2023, Stefan Schnekenburger expands the Executive Board of Schölly Fiberoptic GmbH and takes over the chairmanship from Prof. Dr. Holger Reinecke. Mr. Schnekenburger was most recently responsible for supply chain management and procurement at B. Braun's surgery division Aesculap.

Stefan Schnekenburger (Image: Aesculap AG)

Prof. Dr. Holger Reinecke will step down from the management of Schölly Fiberoptic GmbH on January 1, 2024, and continue his work as a member of the Management Board for Research & Development and Regulatory Affairs at Aesculap AG.

"I am very pleased that with Stefan Schnekenburger comes an experienced industrial engineer who has known Schölly for a long time from his time as Managing Director of the former joint venture Aesculap Fleximed. Together, we will enable a seamless transition in the chairmanship of the management board," says Prof. Dr. Holger Reinecke, who has led the Schölly since January 2015.

Stefan Schnekenburger has 19 years of experience in various areas at medical technology companies. At Aesculap, he initially headed Technical Service and took over Supply Chain Management in 2017.

"I am very happy to accept the challenge and look forward to continuing the 50-year Schölly success story together with the employees," said Stefan Schnekenburger in his first reaction.


More information

Schölly Fiberoptic GmbH is a globally active company with family values headquartered in Denzlingen, Baden-Württemberg. The focus is on engineering, registration, production, and worldwide service of customer-specific visualization systems for the business fields Medical Endoscopy and Visual Inspection. From endoscopes, camera systems and light modules to complex visualization systems, the company offers a wide range of products and services. The entire range of products and services is designed to provide users with an excellent view of their field of application and to open up new perspectives for health and technical progress. The company was founded in 1973 and employs more than 550 people worldwide; about 350 of them in Denzlingen. The six sales and service subsidiaries, together with the headquarters, are responsible for the support of globally active customers as well as for the acquisition of new projects. The share of development costs is over 10 percent.

Aesculap AG has been the sole shareholder since January 2023.

More information at www.schoelly.de.


Ina Vosseler
Senior Manager Marketing Communications
Tel. +49 7666 908145